Metabolic Stability and Comprehensive Metabolite Profiling of Chrysotobibenzyl in Human Liver Microsomes and Hepatocytes Employing UPLC‐MS/MS and UPLC‐Orbitrap‐HRMS Analysis

Documenti analoghi

• Pharmacokinetics and Metabolism of ARV‐393, a BCL6 PROTAC Degrader, in Dogs by UPLC–MS/MS and UPLC‐Q‐Exactive Orbitrap‐HRMS
  di: Qiuyan Wang, et al.
  Pubblicazione: (2026)
• Identification and Multidimensional Evaluation of Quality Markers in Yupingfeng via UPLC‐Q‐Orbitrap‐MS, Network Pharmacology, UPLC‐UV Fingerprint, and UPLC‐QQQ‐MS
  di: Shu Li, et al.
  Pubblicazione: (2026)
• Pharmacokinetic and Metabolism Study of Ginkgolide C in Rats by UPLC‐Q‐TOF‐MS and UPLC‐MS/MS
  di: Yanling Hao, et al.
  Pubblicazione: (2025)
• Evaluation of Niraparib Metabolic Stability in Human Liver Microsomes Using Ultrafast UPLC‐MS/MS Technique: In Silico Screening for Structural Alerts Related to the Metabolic Lability and In Silico DEREK Toxicity
  di: Mohamed W. Attwa, et al.
  Pubblicazione: (2025)
• Quantitative Analysis of the Active Metabolite of VX‐150 Using UPLC–MS/MS: A Preclinical Pharmacokinetic Study in Rats
  di: Xia Feng, et al.
  Pubblicazione: (2025)